NASDAQ · IXHL
Incannex Healthcare Limited
$2.58-$0.13 (-4.8%)
Incannex Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 82.7% below the high.
Loading market information…
ASX · AJJ.AX · AUD
Stock price, dividends, earnings
Quote as of Nov 17, 2021, 11:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Asian American Medical Group Limited’s forward annual dividend is A$0.00 per share, paid semi-annual. The forward yield is 5.26% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Asian American Medical Group Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in Singapore in 1994, Asian American Medical Group Limited (AAMG) delivers specialized healthcare services for liver diseases throughout Singapore and across the broader Asian region. Its operational scope encompasses various segments: Liver services, offering medical consultation and care in hepatology and related fields, including transplantation; Multi-Speciality services, providing diverse medical consultations, particularly within China's medical pilot zones; Management and Consultancy services for healthcare; and the development of Healthcare Real Estate projects. The company operated under the name Asian Centre for Liver Diseases and Transplantation Limited until it adopted its current name in December 2012.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:56 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.58-$0.13 (-4.8%)
Incannex Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 82.7% below the high.
$8.72+$0.39 (+4.68%)
Kazia Therapeutics Ltd ADR’s quoted price sits in the lower half of its reported 52-week range, 49.89% below the high.
A$0.04A$0.00 (0.0%)
CardieX Limited’s quoted price sits in the lower half of its reported 52-week range, 79.43% below the high.
A$0.42+A$0.01 (+2.44%)
MGC Pharmaceuticals Limited’s quoted price sits in the lower half of its reported 52-week range, 96.18% below the high.
A$0.04A$0.00 (0.0%)
AusCann Group Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 4.76% below the high.
A$0.01+A$0.00 (+22.22%)
1st Group Limited’s quoted price sits in the upper half of its reported 52-week range, 26.67% below the high.
A$6.60A$0.00 (0.0%)
Medlab Clinical Limited: Healthcare · Biotechnology.
A$0.01-A$0.00 (-10.0%)
Bionomics Limited’s quoted price sits in the lower half of its reported 52-week range, 87.84% below the high.
